Please assess the completion status of the following clinical trial:

Trial Title: Removal of Palpable Subdermal Contraceptive Rod Implants.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Female age 18 or older~* Willing to remove a palpable subdermal Implanon/ Neplanon CI~* Willing and able to give written informed consent for participation in the investigation~* Willing to provide follow-up information according to the Clinical Investigators Brouchure~Exclusion Criteria:~* Known allergy to local anaesthetic (lidocaine/lignocaine) or disinfectant (chlorhexidine).~* Active skin lesion over the CI.~* The Investigator considers the subject unlikely to comply with investigational procedures, restrictions and requirements.~* Any contraindication for removal of the PI, as judged by the Investigator.~* Any disorders or medications that might affect coagulation, as judged by the Investigator.~* Any conditions suspected to affect healing or increase risk of infection (e.g. keloid tendency, diabetes or any upper arm dermatological condition that may affect upper arm healing).

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- New IMD (Type: EXPERIMENTAL): Subjects with contraceptive implants to be removed, are subjected to the novel device by personnel skilled in traditional removal.

Based on this trial design, predict the completion outcome and termination type (if applicable).